NO20041187L - Metoder og blandinger av nye triazinforbindelser - Google Patents
Metoder og blandinger av nye triazinforbindelserInfo
- Publication number
- NO20041187L NO20041187L NO20041187A NO20041187A NO20041187L NO 20041187 L NO20041187 L NO 20041187L NO 20041187 A NO20041187 A NO 20041187A NO 20041187 A NO20041187 A NO 20041187A NO 20041187 L NO20041187 L NO 20041187L
- Authority
- NO
- Norway
- Prior art keywords
- mixtures
- methods
- triazine compounds
- novel triazine
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/42—One nitrogen atom
- C07D251/44—One nitrogen atom with halogen atoms attached to the two other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/42—One nitrogen atom
- C07D251/46—One nitrogen atom with oxygen or sulfur atoms attached to the two other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
- C07D251/50—Two nitrogen atoms with a halogen atom attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
- C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/54—Three nitrogen atoms
- C07D251/70—Other substituted melamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cosmetics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32414701P | 2001-09-21 | 2001-09-21 | |
| PCT/US2002/030177 WO2003024926A2 (en) | 2001-09-21 | 2002-09-23 | Methods and compositions of novel triazine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20041187L true NO20041187L (no) | 2004-05-19 |
Family
ID=23262298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20041187A NO20041187L (no) | 2001-09-21 | 2004-03-22 | Metoder og blandinger av nye triazinforbindelser |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1436266A4 (no) |
| JP (1) | JP2005511509A (no) |
| KR (1) | KR20040088457A (no) |
| CN (1) | CN1578773A (no) |
| BR (1) | BR0212895A (no) |
| CA (1) | CA2461074A1 (no) |
| EA (1) | EA009728B1 (no) |
| IL (1) | IL160984A0 (no) |
| IS (1) | IS7190A (no) |
| MX (1) | MXPA04002680A (no) |
| NO (1) | NO20041187L (no) |
| NZ (1) | NZ532349A (no) |
| PL (1) | PL369600A1 (no) |
| RS (1) | RS34004A (no) |
| WO (1) | WO2003024926A2 (no) |
| ZA (1) | ZA200403009B (no) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7163943B2 (en) | 2001-09-21 | 2007-01-16 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7132423B2 (en) | 2001-09-21 | 2006-11-07 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7173032B2 (en) | 2001-09-21 | 2007-02-06 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7169785B2 (en) | 2001-09-21 | 2007-01-30 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| US7112587B2 (en) | 2001-09-21 | 2006-09-26 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
| ATE511858T1 (de) | 2002-02-05 | 2011-06-15 | Astellas Pharma Inc | 2,4,6-triamino-1,3,5-triazin-derivat |
| AU2003253735A1 (en) * | 2002-06-25 | 2004-01-06 | The Center For Blood Research, Inc. | Vacuolins |
| AU2004259346A1 (en) * | 2003-07-22 | 2005-02-03 | Neurogen Corporation | Substituted pyridin-2-ylamine analogues |
| CN1629157A (zh) * | 2003-12-19 | 2005-06-22 | 中国科学院上海药物研究所 | 哌嗪三嗪类化合物、其制备方法及药物组合物 |
| US7335770B2 (en) | 2004-03-24 | 2008-02-26 | Reddy U5 Therapeutics, Inc. | Triazine compounds and their analogs, compositions, and methods |
| CN101588800B (zh) * | 2006-11-03 | 2012-01-04 | 内尔维阿诺医学科学有限公司 | 给药抗肿瘤化合物的方法 |
| KR101314869B1 (ko) * | 2010-07-29 | 2013-10-04 | 광주과학기술원 | 트리아진계 화합물을 유효성분으로 포함하는 당뇨병 예방 또는 치료용 약제학적 조성물 |
| US20120295911A1 (en) | 2010-11-29 | 2012-11-22 | Galleon Pharmaceuticals, Inc. | Novel Compounds and Compositions for Treatment of Breathing Control Disorders or Diseases |
| JP5907986B2 (ja) * | 2010-11-29 | 2016-04-26 | ガリオン ファーマシューティカルズ インコーポレイテッド | 呼吸制御障害または呼吸制御疾患の処置用の呼吸刺激薬としての化合物 |
| AU2016379444B2 (en) | 2015-12-24 | 2021-04-29 | The Regents Of The University Of California | CFTR regulators and methods of use thereof |
| CA3073718A1 (en) | 2017-08-24 | 2019-02-28 | The Regents Of The University Of California | Ocular pharmaceutical compositions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2083568C1 (ru) * | 1994-05-05 | 1997-07-10 | Кубанский государственный аграрный университет | Соли триазинкарбоновых кислот и средство для предпосевной обработки семян сельскохозяйственных культур |
| DE19531084A1 (de) * | 1995-08-24 | 1997-02-27 | Hoechst Schering Agrevo Gmbh | 2,4-Diamino-1,3,5-triazine, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren |
| DK1037886T3 (da) * | 1997-12-12 | 2003-08-25 | Abbott Lab | Triazin angiogeneseinhibitorer |
| EP0945447A1 (en) * | 1998-03-27 | 1999-09-29 | Janssen Pharmaceutica N.V. | Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections |
| AU2457201A (en) * | 1999-12-28 | 2001-07-09 | Bristol-Myers Squibb Company | Cytokine, especially tnf-alpha, inhibitors |
| AU2002216650A1 (en) * | 2000-10-31 | 2002-05-15 | Lynn Bonham | Triazine derivatives as lpaat-b inhibitors and uses thereof |
-
2002
- 2002-09-23 MX MXPA04002680A patent/MXPA04002680A/es active IP Right Grant
- 2002-09-23 CA CA002461074A patent/CA2461074A1/en not_active Abandoned
- 2002-09-23 IL IL16098402A patent/IL160984A0/xx unknown
- 2002-09-23 RS YU34004A patent/RS34004A/sr unknown
- 2002-09-23 PL PL02369600A patent/PL369600A1/xx not_active Application Discontinuation
- 2002-09-23 EA EA200400464A patent/EA009728B1/ru not_active IP Right Cessation
- 2002-09-23 BR BR0212895-0A patent/BR0212895A/pt not_active IP Right Cessation
- 2002-09-23 CN CNA028232402A patent/CN1578773A/zh active Pending
- 2002-09-23 JP JP2003528774A patent/JP2005511509A/ja active Pending
- 2002-09-23 NZ NZ532349A patent/NZ532349A/en unknown
- 2002-09-23 WO PCT/US2002/030177 patent/WO2003024926A2/en active Application Filing
- 2002-09-23 KR KR10-2004-7004179A patent/KR20040088457A/ko not_active Application Discontinuation
- 2002-09-23 EP EP02799019A patent/EP1436266A4/en not_active Withdrawn
-
2004
- 2004-03-19 IS IS7190A patent/IS7190A/is unknown
- 2004-03-22 NO NO20041187A patent/NO20041187L/no not_active Application Discontinuation
- 2004-04-20 ZA ZA200403009A patent/ZA200403009B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IS7190A (is) | 2004-03-19 |
| EP1436266A2 (en) | 2004-07-14 |
| WO2003024926A2 (en) | 2003-03-27 |
| EA009728B1 (ru) | 2008-02-28 |
| EA200400464A1 (ru) | 2005-02-24 |
| IL160984A0 (en) | 2004-08-31 |
| MXPA04002680A (es) | 2004-06-18 |
| RS34004A (en) | 2006-10-27 |
| WO2003024926A3 (en) | 2003-12-11 |
| BR0212895A (pt) | 2005-05-10 |
| CN1578773A (zh) | 2005-02-09 |
| PL369600A1 (en) | 2005-05-02 |
| KR20040088457A (ko) | 2004-10-16 |
| EP1436266A4 (en) | 2004-12-22 |
| JP2005511509A (ja) | 2005-04-28 |
| NZ532349A (en) | 2007-02-23 |
| CA2461074A1 (en) | 2003-03-27 |
| ZA200403009B (en) | 2007-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20041187L (no) | Metoder og blandinger av nye triazinforbindelser | |
| NO20041975D0 (no) | Bicyklisk oksopyridin og oksopyrimidinderivater | |
| NO20042147L (no) | Heterocykliske forbindelser og fremgangsmater for anvendelse derav | |
| DK1400518T3 (da) | Heterocycliske forbindelser og lægemidler | |
| DK1373224T3 (da) | Nye spirotricykliske derivater og deres anvendelse som phosphodiesterase 7 inhibitorer | |
| DE60212600D1 (de) | Audiocodierung und decodierung | |
| NO20052348D0 (no) | Behandling av hemoragisk sjokk | |
| DE50212455D1 (de) | Verwendung von Dimerdiolen | |
| NO20033854D0 (no) | N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse | |
| NO20040390L (no) | Krystallinske former VI og VII av atorvastatinkalsium. | |
| NO20033797L (no) | Metode og formel for anti-tumor og anti-metastatisk virkning | |
| IS7128A (is) | Hreinsun á zaleploni og kristölluð form þess | |
| NO20041968L (no) | Anvendelse av cystationin | |
| NO20032440L (no) | Fremgangsmåte for fremstillingen av iopamidol og de nye intermediater deri | |
| NO20030822L (no) | Nye forbindelser og fremgangsmåter | |
| IS7020A (is) | Kornóttar blöndur Gaboxadols | |
| PT1392670E (pt) | Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina | |
| NO20040479L (no) | Solvater av lerkanidipinhydroklorid og nye krystallinske former av lerkanidipinhydroklorid. | |
| NO20042126L (no) | Syntese av 2-aralkoksyadenosiner og 2-alkoksyadenosiner | |
| NO20033743L (no) | Fremgangsmåte og fremstilling citalopram | |
| NO20040346L (no) | Ny krystall av aryletensulfonamid-derivat og fremstillingsprosess derav | |
| DE60214142D1 (de) | Flavonoidverbindung und herstellungsverfahren dafür | |
| NO20034972D0 (no) | Behandling av ADHD | |
| ATE354561T1 (de) | Substituierte 1-aryl-but-3-enylamin- und 1-aryl- but-2-enylaminverbindungen | |
| NO20035647D0 (no) | Ny anvendelse av cyclolignaner og nye cycloliganer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |